{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:40Z","timestamp":1791918940583,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T00:00:00Z","timestamp":1221609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s11060-008-9693-3","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T19:50:51Z","timestamp":1221594651000},"page":"175-182","source":"Crossref","is-referenced-by-count":101,"title":["A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)"],"prefix":"10.1007","volume":"91","author":[{"given":"Nicholas","family":"Butowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Junck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Abrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Lamborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M.","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Prados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,17]]},"reference":[{"issue":"10","key":"9693_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. doi: 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"1","key":"9693_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/bjc.1987.161","volume":"56","author":"SP Stenning","year":"1987","unstructured":"Stenning SP, Freedman LS, Bleehen NM (1987) An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer 56(1):89\u201390","journal-title":"Br J Cancer"},{"issue":"9311","key":"9693_CR3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","volume":"359","author":"LA Stewart","year":"2002","unstructured":"Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359(9311):1011\u20131018. doi: 10.1016\/S0140-6736(02)08091-1","journal-title":"Lancet"},{"issue":"8","key":"9693_CR4","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S","volume":"71","author":"HA Fine","year":"1993","unstructured":"Fine HA et al (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71(8):2585\u20132597. doi:10.1002\/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S","journal-title":"Cancer"},{"issue":"3","key":"9693_CR5","first-page":"1058","volume":"45","author":"JE Talmadge","year":"1985","unstructured":"Talmadge JE et al (1985) Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-l-lysine and carboxymethylcellulose. Cancer Res 45(3):1058\u20131065","journal-title":"Cancer Res"},{"key":"9693_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1980.tb20604.x","volume":"350","author":"HB Levy","year":"1980","unstructured":"Levy HB et al (1980) Immune modulating effects of poly ICLC. Ann N Y Acad Sci 350:33\u201341. doi: 10.1111\/j.1749-6632.1980.tb20604.x","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"9693_CR7","first-page":"3252","volume":"44","author":"HR Hubbell","year":"1984","unstructured":"Hubbell HR, Liu RS, Maxwell BL (1984) Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA. Cancer Res 44(8):3252\u20133257","journal-title":"Cancer Res"},{"issue":"8","key":"9693_CR8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0192-0561(92)90005-6","volume":"14","author":"PL Black","year":"1992","unstructured":"Black PL et al (1992) Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-l-lysine in carboxymethyl cellulose [Poly(I, C)-LC]. Int J Immunopharmacol 14(8):1341\u20131353. doi: 10.1016\/0192-0561(92)90005-6","journal-title":"Int J Immunopharmacol"},{"issue":"4","key":"9693_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00148390","volume":"5","author":"RS Dick","year":"1987","unstructured":"Dick RS, Hubbell HR (1987) Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations. J Neurooncol 5(4):331\u2013338. doi: 10.1007\/BF00148390","journal-title":"J Neurooncol"},{"issue":"2","key":"9693_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jir.1990.10.141","volume":"10","author":"MG Rosenblum","year":"1990","unstructured":"Rosenblum MG et al (1990) Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2\u2032,5\u2032-oligoadenylate synthetase and protein kinase activity. J Interferon Res 10(2):141\u2013151","journal-title":"J Interferon Res"},{"issue":"4","key":"9693_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000421-198708000-00003","volume":"10","author":"DR Strayer","year":"1987","unstructured":"Strayer DR et al (1987) Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons. Am J Clin Oncol 10(4):281\u2013284. doi: 10.1097\/00000421-198708000-00003","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"9693_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-5347(17)43953-X","volume":"137","author":"MJ Droller","year":"1987","unstructured":"Droller MJ (1987) Immunotherapy of metastatic renal cell carcinoma with polyinosinic-polycytidylic acid. J Urol 137(2):202\u2013206","journal-title":"J Urol"},{"issue":"6","key":"9693_CR13","first-page":"664","volume":"4","author":"MJ Hawkins","year":"1985","unstructured":"Hawkins MJ, Levin M, Borden EC (1985) An Eastern Cooperative Oncology Group phase I\u2013II pilot study of polyriboinosinic-polyribocytidylic acid poly-l-lysine complex in patients with metastatic malignant melanoma. J Biol Response Mod 4(6):664\u2013668","journal-title":"J Biol Response Mod"},{"issue":"6","key":"9693_CR14","first-page":"640","volume":"4","author":"SE Krown","year":"1985","unstructured":"Krown SE et al (1985) Phase I trials of poly(I, C) complexes in advanced cancer. J Biol Response Mod 4(6):640\u2013649","journal-title":"J Biol Response Mod"},{"issue":"1","key":"9693_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.1982.2.1","volume":"2","author":"O Nakamura","year":"1982","unstructured":"Nakamura O et al (1982) Phase I-II trials of poly(ICLC) in malignant brain tumor patients. J Interferon Res 2(1):1\u20134","journal-title":"J Interferon Res"},{"issue":"3","key":"9693_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0090-8258(86)90313-6","volume":"24","author":"MA Rettenmaier","year":"1986","unstructured":"Rettenmaier MA, Berman ML, DiSaia PJ (1986) Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly ICLC). Gynecol Oncol 24(3):359\u2013361. doi: 10.1016\/0090-8258(86)90313-6","journal-title":"Gynecol Oncol"},{"issue":"11","key":"9693_CR17","first-page":"1341","volume":"70","author":"RL Theriault","year":"1986","unstructured":"Theriault RL et al (1986) Evaluation of polyinosinic-polycytidylic and poly-l-lysine in metastatic breast cancer. Cancer Treat Rep 70(11):1341\u20131342","journal-title":"Cancer Treat Rep"},{"issue":"4","key":"9693_CR18","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.135.4.2483","volume":"135","author":"JE Talmadge","year":"1985","unstructured":"Talmadge JE et al (1985) Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. J Immunol 135(4):2483\u20132491","journal-title":"J Immunol"},{"issue":"11","key":"9693_CR19","first-page":"3005","volume":"52","author":"CH Ewel","year":"1992","unstructured":"Ewel CH et al (1992) Polyinosinic-polycytidylic acid complexed with poly-l-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. Cancer Res 52(11):3005\u20133010","journal-title":"Cancer Res"},{"issue":"1","key":"9693_CR20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3171\/jns.1992.77.1.0120","volume":"77","author":"KL Black","year":"1992","unstructured":"Black KL et al (1992) Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J Neurosurg 77(1):120\u2013126","journal-title":"J Neurosurg"},{"issue":"5","key":"9693_CR21","first-page":"475","volume":"4","author":"HB Levy","year":"1985","unstructured":"Levy HB (1985) Historical overview of the use of polynucleotides in cancer. J Biol Response Mod 4(5):475\u2013480","journal-title":"J Biol Response Mod"},{"key":"9693_CR22","first-page":"653","volume":"41","author":"HB Levy","year":"1981","unstructured":"Levy HB, Levine AS (1981) Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man. Tex Rep Biol Med 41:653\u2013662","journal-title":"Tex Rep Biol Med"},{"issue":"7","key":"9693_CR23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","volume":"60","author":"M Matsumoto","year":"2008","unstructured":"Matsumoto M, Seya T (2008) TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 60(7):805\u2013812","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"9693_CR24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2567.2007.02799.x","volume":"124","author":"H Kim","year":"2008","unstructured":"Kim H et al (2008) Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology 124(4):480\u2013488","journal-title":"Immunology"},{"key":"9693_CR25","first-page":"277","volume":"383","author":"S Balachandran","year":"2007","unstructured":"Balachandran S, Barber GN (2007) PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol 383:277\u2013301. doi: 10.1007\/978-1-59745-335-6_18","journal-title":"Methods Mol Biol"},{"issue":"6","key":"9693_CR26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1227\/00006123-199606000-00006","volume":"38","author":"AM Salazar","year":"1996","unstructured":"Salazar AM et al (1996) Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery 38(6):1096\u20131103. doi: 10.1097\/00006123-199606000-00006 discussion 1103\u20131104","journal-title":"Neurosurgery"},{"issue":"1","key":"9693_CR27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejca.2006.08.024","volume":"43","author":"W Liu","year":"2007","unstructured":"Liu W et al (2007) Tumour suppressor function of RNase l in a mouse model. Eur J Cancer 43(1):202\u2013209. doi: 10.1016\/j.ejca.2006.08.024","journal-title":"Eur J Cancer"},{"issue":"22","key":"9693_CR28","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1073\/pnas.91.22.10551","volume":"91","author":"SB Lee","year":"1994","unstructured":"Lee SB et al (1994) Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain. Proc Natl Acad Sci U S A 91(22):10551\u201310555. doi: 10.1073\/pnas.91.22.10551","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9693_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000029974","volume":"19","author":"GK Haines III","year":"1998","unstructured":"Haines GKIII et al (1998) Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma. Tumour Biol 19(1):52\u201359. doi: 10.1159\/000029974","journal-title":"Tumour Biol"},{"issue":"1","key":"9693_CR30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1073\/pnas.90.1.232","volume":"90","author":"EF Meurs","year":"1993","unstructured":"Meurs EF et al (1993) Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 90(1):232\u2013236. doi: 10.1073\/pnas.90.1.232","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9693_CR31","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1210\/endo.143.6.8835","volume":"143","author":"MS Chacko","year":"2002","unstructured":"Chacko MS, Ma X, Adamo ML (2002) Double-stranded ribonucleic acid decreases c6 rat glioma cell proliferation in part by activating protein kinase R and decreasing insulin-like growth factor I levels. Endocrinology 143(6):2144\u20132154. doi: 10.1210\/en.143.6.2144","journal-title":"Endocrinology"},{"issue":"20","key":"9693_CR32","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1016\/S0021-9258(19)86690-5","volume":"254","author":"MA Minks","year":"1979","unstructured":"Minks MA et al (1979) Structural requirements of double-stranded RNA for the activation of 2\u2032, 5\u2032-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem 254(20):10180\u201310183","journal-title":"J Biol Chem"},{"issue":"3","key":"9693_CR33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1432-1033.1989.tb14485.x","volume":"178","author":"J Galabru","year":"1989","unstructured":"Galabru J et al (1989) The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur J Biochem 178(3):581\u2013589. doi: 10.1111\/j.1432-1033.1989.tb14485.x","journal-title":"Eur J Biochem"},{"issue":"5\u20136","key":"9693_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cytogfr.2007.06.003","volume":"18","author":"AG Hovanessian","year":"2007","unstructured":"Hovanessian AG (2007) On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2\u2032-5\u2032oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev 18(5\u20136):351\u2013361","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"9693_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/jir.1991.11.199","volume":"11","author":"AG Hovanessian","year":"1991","unstructured":"Hovanessian AG (1991) Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2\u2032,5\u2032-oligoadenylate synthetases. J Interferon Res 11(4):199\u2013205","journal-title":"J Interferon Res"},{"issue":"6","key":"9693_CR36","first-page":"656","volume":"4","author":"AE Maluish","year":"1985","unstructured":"Maluish AE et al (1985) Immunomodulatory effects of poly(I, C)-LC in cancer patients. J Biol Response Mod 4(6):656\u2013663","journal-title":"J Biol Response Mod"},{"issue":"7","key":"9693_CR37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR et al (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8(7):1277\u20131280","journal-title":"J Clin Oncol"},{"issue":"9","key":"9693_CR38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","volume":"85","author":"WJ Curran Jr","year":"1993","unstructured":"Curran WJ Jr et al (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85(9):704\u2013710. doi: 10.1093\/jnci\/85.9.704","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9693_CR39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1200\/JCO.2002.20.5.1375","volume":"20","author":"R Stupp","year":"2002","unstructured":"Stupp R et al (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20(5):1375\u20131382. doi: 10.1200\/JCO.20.5.1375","journal-title":"J Clin Oncol"},{"issue":"16","key":"9693_CR40","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1517\/14656566.6.16.2813","volume":"6","author":"G Chong","year":"2005","unstructured":"Chong G, Morse MA (2005) Combining cancer vaccines with chemotherapy. Expert Opin Pharmacother 6(16):2813\u20132820. doi: 10.1517\/14656566.6.16.2813","journal-title":"Expert Opin Pharmacother"},{"issue":"16","key":"9693_CR41","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1158\/1078-0432.CCR-04-0497","volume":"10","author":"CJ Wheeler","year":"2004","unstructured":"Wheeler CJ et al (2004) Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin Cancer Res 10(16):5316\u20135326. doi: 10.1158\/1078-0432.CCR-04-0497","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9693_CR42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/0008-5472.CAN-05-2967","volume":"66","author":"RG Most van der","year":"2006","unstructured":"van der Most RG et al (2006) Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity. Cancer Res 66(2):601\u2013604. doi: 10.1158\/0008-5472.CAN-05-2967","journal-title":"Cancer Res"},{"key":"9693_CR43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-5-10","volume":"5","author":"X Zhu","year":"2007","unstructured":"Zhu X et al (2007) Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med 5:10. doi: 10.1186\/1479-5876-5-10","journal-title":"J Transl Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9693-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-008-9693-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9693-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:49:01Z","timestamp":1684540141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-008-9693-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,17]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["9693"],"URL":"https:\/\/doi.org\/10.1007\/s11060-008-9693-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,17]]}}}